Venus Remedies Limited vs Zydus Lifesciences Limited
A side-by-side comparison of Venus Remedies Limited (VENUSREM) and Zydus Lifesciences Limited (ZYDUSLIFE) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
Venus Remedies Limited vs Zydus Lifesciences Limited are evenly matched on the numbers (7–7). The breakdown below shows where each one wins.
- Valuation40
- Profitability13
- Growth11
- Size & financial health13
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
VENUSREM takes 4/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
ZYDUSLIFE takes 3/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
EvenThree-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
ZYDUSLIFE takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company is almost debt free."]
- − ["The company has delivered a poor sales growth of 7.2% over past five years."]
- + ["Company has delivered good profit growth of 18.6% CAGR over last 5 years", "Company has a good return on equity (ROE) track record: 3 Years ROE 20.9%"]
- − []
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.